News & Blog
Posted on 16 July 2026
What Investors Are Looking for in Emerging Biotech Companies
by Haiqa Rashid
Posted on 16 July 2026
Rethinking Neurodegenerative Disease Treatment: A Conversation with Alan Palmer, CEO of Elixa Mediscience
by Muhammad Younis
Posted on 16 July 2026
Biotech Market Snapshot: April 2026 Review
by Sadaf Hamdani
Posted on 16 July 2026
Why 2026 Will Be a Defining Year for Global Biotech Collaboration
by Sadaf Hamdani
Posted on 16 July 2026
Novartis and Relation Therapeutics Enter Strategic Collaboration to Advance Atopic Disease Treatments
by Sadaf Hamdani
Posted on 16 July 2026
Reprocessed Nuclear Material to Support Next-Generation Cancer Therapies in the UK
by Sadaf Hamdani
Posted on 16 July 2026
Collaboration Models That Work: How Academia, Big Pharma & Startups Are Co-Innovating
by Sadaf Hamdani
Posted on 8 September 2026
EASEE4YOU Clinical Study Begins in the UK as GOSH Joins Evaluation of New Neurostimulation Therapy
by Sadaf Hamdani
Posted on 16 July 2026
Newcastle Launches the UK’s First National Centre for Neurotechnology and Neurorestoration
by Sadaf Hamdani


